Educational delay and attainment in persons with neurofibromatosis 1 in Denmark.
Journal
European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
24
05
2018
accepted:
24
01
2019
revised:
20
12
2018
pubmed:
2
3
2019
medline:
12
6
2020
entrez:
2
3
2019
Statut:
ppublish
Résumé
Most research on psychosocial consequences of neurofibromatosis type 1 (NF1) has focused on the relationship between disease factors and cognitive functioning. NF1 may impair domains of learning and attention, resulting in low academic performance. This study is the first nationwide population-based cohort study to investigate educational attainment and delay in completing mandatory school by persons with NF1. Educational information was collected from 550 persons at the age of 30 (born 1965-1984). They were diagnosed with NF1 in Denmark and compared to a cohort of NF1-free persons matched on gender and age (n = 4295). Multinomial logistic models were applied to estimate odds ratios (ORs) for obtaining short (≤9 years) or medium (10-12 years) education compared to long education (>12 years) by the age of 30 years. We calculated the probability of graduating 9
Identifiants
pubmed: 30820037
doi: 10.1038/s41431-019-0359-8
pii: 10.1038/s41431-019-0359-8
pmc: PMC6777448
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
857-868Commentaires et corrections
Type : ErratumIn
Références
Expert Rev Neurother. 2014 Jul;14(7):799-812
pubmed: 24894408
Child Neuropsychol. 2008 Sep;14(5):401-18
pubmed: 17963094
Orphanet J Rare Dis. 2011 May 04;6:18
pubmed: 21542925
Am J Med Genet. 1997 May 16;70(2):138-43
pubmed: 9128932
Biometrics. 2000 Jun;56(2):645-6
pubmed: 10877330
Am J Hum Genet. 2001 May;68(5):1110-8
pubmed: 11283797
Clin Genet. 2015 Nov;88(5):425-30
pubmed: 25534182
J Genet Couns. 2015 Dec;24(6):931-44
pubmed: 25894096
J Child Neurol. 2002 Aug;17(8):622-6; discussion 627-9, 646-51
pubmed: 12403561
Scand J Public Health. 2011 Jul;39(7 Suppl):54-7
pubmed: 21775352
Scand J Public Health. 2011 Jul;39(7 Suppl):30-3
pubmed: 21775347
J Atten Disord. 2007 Sep;11(2):101-5
pubmed: 17494836
Anticancer Res. 2014 Jul;34(7):3675-81
pubmed: 24982386
Dan Med Bull. 2006 Nov;53(4):441-9
pubmed: 17150149
Dev Med Child Neurol. 2006 Dec;48(12):973-7
pubmed: 17109785
J Intellect Disabil Res. 2005 Jan;49(Pt 1):33-46
pubmed: 15634310
Behav Genet. 2006 Sep;36(5):660-4
pubmed: 16474913
J Child Neurol. 2008 Sep;23(9):1002-10
pubmed: 18827266
Am J Med Genet B Neuropsychiatr Genet. 2012 Oct;159B(7):869-73
pubmed: 22911924
Neuropsychol Rehabil. 2014;24(6):918-35
pubmed: 24875728
Dev Neuropsychol. 2012;37(7):590-600
pubmed: 23066937
Eur J Hum Genet. 2011 Nov;19(11):1187-91
pubmed: 21694737
J Am Acad Dermatol. 2009 Jul;61(1):1-14; quiz 15-6
pubmed: 19539839
Child Neuropsychol. 2010;16(5):417-32
pubmed: 20521183
Dev Med Child Neurol. 2004 Aug;46(8):553-63
pubmed: 15287247
Lancet Neurol. 2007 Apr;6(4):340-51
pubmed: 17362838
Br J Cancer. 2004 Aug 31;91(5):923-8
pubmed: 15292930
Pain Res Treat. 2012;2012:975364
pubmed: 23056937
Pediatrics. 2009 Jan;123(1):124-33
pubmed: 19117870
Front Hum Neurosci. 2014 Jun 06;8:386
pubmed: 24936179
J Intellect Disabil Res. 2013 Sep;57(9):874-86
pubmed: 23095048
Scand J Public Health. 2011 Jul;39(7 Suppl):91-4
pubmed: 21775362
Am J Med Genet. 1999 Mar 26;89(1):45-52
pubmed: 10469436
Neurology. 2005 Oct 11;65(7):1037-44
pubmed: 16217056